Integrative biomarker and drug target discovery in osteosarcoma: traditional experimental approaches and AI-enabled insights

Zhihao Gao, Chongqin Wu

Open source

DOI
10.3389/fphar.2026.1791228
Published
2026-04-07
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1791228,
  title = {Integrative biomarker and drug target discovery in osteosarcoma: traditional experimental approaches and AI-enabled insights},
  author = {Zhihao Gao and Chongqin Wu},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1791228},
  url = {https://doi.org/10.3389/fphar.2026.1791228}
}

RIS

TY  - JOUR
TI  - Integrative biomarker and drug target discovery in osteosarcoma: traditional experimental approaches and AI-enabled insights
AU  - Zhihao Gao
AU  - Chongqin Wu
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1791228
UR  - https://doi.org/10.3389/fphar.2026.1791228
ER  - 

APA

Gao, Z., & Wu, C. (2026). Integrative biomarker and drug target discovery in osteosarcoma: traditional experimental approaches and AI-enabled insights. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1791228

Source records